Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 72162-1514

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide (NDC 72162-1514). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721621514)

Label (Lbl721621514)
Label for Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide tablets 20 mg/5 mg/12.5 mg. The label indicates 90 film-coated tablets per bottle, relabeled by Bryant Ranch Prepack and manufactured by Par Pharmaceutical. It includes dosage strengths, storage instructions, and barcode elements.*
FDA Label Image

Olmesartan Medoxomil (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 1)

Olmesartan Medoxomil (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 1)
Chemical structure diagram depicting the molecular structure of olmesartan medoxomil, one of the active ingredients in the olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide combination drug.*
FDA Label Image

Amlodipine Besylate (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 2)

Amlodipine Besylate (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 2)
Chemical structure of olmesartan medoxomil and amlodipine besylate as depicted in the image, showing their molecular arrangements with labeled atoms and bonds.*
FDA Label Image

Hydrochlorothiazide (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 3)

Hydrochlorothiazide (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 3)
Chemical structure of the active ingredient amlodipine besylate, depicted with its characteristic dihydropyridine ring and sulfonamide groups.*
FDA Label Image

Figure 1 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 4)

Figure 1 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 4)
A line chart showing multiple data series with different markers (circles, triangles, diamonds, squares) representing baseline and varying combinations of olmesartan medoxomil and hydrochlorothiazide doses. The vertical axis ranges from 55 to 100, while the horizontal axis has unlabeled time points or categories. The legend identifies the data series but the text is partially unreadable.*
FDA Label Image

Figure 2 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 5)

Figure 2 (Olmesartan Medoxomil Amlodipine And Hydrochlorothi 5)
A line graph titled 'Mean Ambulatory Systolic Blood Pressure at Endpoint by Treatment and Hour' showing systolic blood pressure over 24 hours post dose. The x-axis represents hours post dose (0 to 24), and the y-axis represents mean ambulatory systolic blood pressure in mmHg (105 to 160). Multiple treatment groups are displayed with distinct markers indicating baseline and various drug combinations.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.